San Diego, CA, United States of America

Philip W Hammond

This inventor holds 19 USPTO granted patents and 1 published patent application, primarily in Nucleic Acid Probes. Top assignees: Gen-Probe, Inc., Gen-Probe Products Company. Active years: 1990-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip W Hammond. Retrieved from https://idiyas.com/inventor/philip-w-hammond

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 78.9

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 283(Granted Patents)


Location History:

  • Tehachapi, CA (US) (1997 - 2000)
  • San Diego, CA (US) (1990 - 2006)
  • Boulder, CO (US) (2008 - 2013)
  • Ayer, MA (US) (2015)

Company Filing History:


Years Active: 1990-2015

Loading Chart...
Areas of Expertise:
Nucleic Acid Probes
Hybridization Assays
Human Papilloma Virus
Mycobacterium Tuberculosis
Oligonucleotides
Amplification Techniques
Nucleic Acid Detection
Chlamydia Pneumoniae
Chemiluminescent Labels
Mycobacterium Avium
Mycobacterium Kansasii
Streptococcus Pyogenes
19 patents (USPTO):Explore Patents

Title: The Innovations of Philip W. Hammond: Pioneering HPV Detection

Introduction: Philip W. Hammond, an esteemed inventor based in San Diego, CA, has made significant contributions to the field of medical diagnostics with a focus on human papilloma virus (HPV) detection. With a total of 19 patents to his name, his work has advanced the methodologies used in identifying critical viral infections and their associated health implications.

Latest Patents: Hammond's latest patents include innovative hybridization assay detection probes specifically designed for detecting human papilloma virus. One of his notable inventions introduces hybridization assay detection probes that target HPV Type 16 nucleic acid sequences. These oligonucleotides are instrumental in identifying HPV Type 16 in various samples, enhancing the accuracy of diagnostics. In addition, he has developed oligonucleotides aimed at detecting HPV Type 16 and/or Type 18, which can be utilized in multiple capacities, such as hybridization assay probes, helper probes, and amplification primers. These advancements signify a substantial leap forward in the field of virology and diagnostic testing.

Career Highlights: Throughout his career, Philip W. Hammond has been affiliated with prominent companies such as Gen-Probe, Inc. and Gen-Probe Products Company. His extensive experience in these organizations has provided him with a robust platform to innovate and refine techniques for viral detection. His expertise and commitment to research and development have earned him recognition in his field.

Collaborations: Hammond has collaborated with notable peers, including Patricia C. Gordon and Nick Mark Carter. These collaborations have spurred innovative solutions in the realm of medical diagnostics and have contributed to the success of his projects. The synergy between Hammond and his colleagues underscores the importance of teamwork in driving technological advancements.

Conclusion: Philip W. Hammond's contributions to HPV detection signify a remarkable journey of innovation and dedication. With 19 patents exemplifying his prowess, his work continues to influence the fields of diagnostics and virology. Hammond’s ongoing efforts and collaborations highlight the importance of inventive thinking in tackling complex medical challenges, paving the way for improved healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…